ADM	adriamycin
ALG	alginate
BFA	Brefeldin A
CD	cyclodextrin
CE	cellulose
CL	ε-caprolactone
CMCS	carboxymethyl chitosan
CS	chitosan
DL	drug loading
DDSs	drug delivery systems
Dex	dextran
DOX	doxorubici
DSPE	diacylphosphatidylethanolamine
EE	encapsulation efficiency
EPR	enhanced permeability and retention effect
FA	folic acid
FDA	United States Food and Drug Administration
5-FU	5-fluorouracil
GA	glycolide
GMP	Good Manufacturing Practice
GSH	glutathione
HA	hyaluronic acid
LA	lactide
MDR	multidrug resistance
MIP	molecularly imprinted polymer
MOF	metal–organic frameworks
mPEG-PDLLA	methoxy polyethylene glycol-poly(D,L-lactide)
nab-PTX	nab-paclitaxel
nano-DDSs	nano drug delivery systems
NC/NCs	nanocarrier/nanocarriers
NP/NPs	nanoparticle/nanoparticles
NSCLC	non-small cell lung cancer
PA	palmitic acid
PAMAM	poly(amidoamine)
PCL	poly(ε-caprolactone)
PGA	poly(glycolic acid)
PEG	polyethylene glycol
PEO-b-PCL	poly(ethylene oxide)-b-poly(ε-caprolactone) block copolymers
PEO-b-PBCL	poly(ethylene oxide)-b-poly(α-benzyl carboxylate-ε-caprolactone) block copolymers
PHB	poly-3-hydroxybutyrate
PLA	poly(lactic acid)/polylactides
PLLA	poly(L-lactide)
PDLA	poly(D-lactide)
PDLLA	poly(D,L-lactide)
PLGA	glycolide and lactide copolymers
PNIPAAm	poly(N-isopropylacrylamide)
PPC	poly(propylene carbonate)
PTX	paclitaxel
PU	polyurethane
PVA	poly(vinyl alcohol)
PVP	poly(vinyl pyrrolidone)
TME	tumor-microenvironment
TNBC	triple-negative breast cancer
TPGS	D-ɑ-tocopheryl polyethylene glycol succinate
WHO	World Health Organization